To elicit the views of well informed community members on the ethical obligations of general practitioners regarding prostate-specific antigen (PSA) testing, and what should be required before a man undergoes a PSA test.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Three community juries held at the University of Sydney over 6 months in 2014.
Forty participants from New South Wales, of diverse social and cultural backgrounds and with no experience of prostate cancer, recruited through public advertising: two juries of mixed gender and ages; one all-male jury of PSA screening age.
In contrast to Royal Australian College of General Practitioners guidelines, the three juries concluded that GPs should initiate discussions about PSA testing with asymptomatic men over 50 years of age. The mixed juries voted for GPs offering detailed information about all potential consequent benefits and harms before PSA testing, and favoured a cooling-off period before undertaking the test. The all-male jury recommended a staggered approach to providing information. They recommended that written information be available to those who wanted it, but eight of the 12 jurors thought that doctors should discuss the benefits and harms of biopsy and treatment only after a man had received an elevated PSA test result.
Informed jury participants preferred that GPs actively supported individual men in making decisions about PSA testing, and that they allowed a cooling-off period before testing. However, men of screening age argued that uncertain and detailed information should be communicated only after receiving an elevated PSA test result.
The Medical journal of Australia. 2015 Oct 19 [Epub]
Chris Degeling, Lucie Rychetnik, Kristen Pickles, Rae Thomas, Jennifer A Doust, Robert A Gardiner, Paul Glasziou, Ainsley J Newson, Stacy M Carter
University of Sydney, Sydney, University of Notre Dame, Sydney, NSW. , University of Sydney, Sydney, NSW. , Bond University, Gold Coast, QLD. , Bond University, Gold Coast, QLD. , The University of Queensland Centre for Clinical Research, Redland City, QLD. , Bond University, Gold Coast, QLD. , University of Sydney, Sydney, NSW. , University of Sydney, Sydney, NSW.